The company specializes in rapid diagnostics for infectious pathogens through their Accelerate ID/AST System, which determines antibiotic susceptibility of bacterial or fungal cells in a patient sample in just five hours. They also offer the Accelerate Pheno® system and Accelerate PhenoTest® BC kit, which automate sample preparation steps to report antibiotic susceptibility results in approximately seven hours, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier than existing methods.